0000919574-18-005773.txt : 20180820
0000919574-18-005773.hdr.sgml : 20180820
20180820175707
ACCESSION NUMBER: 0000919574-18-005773
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180816
FILED AS OF DATE: 20180820
DATE AS OF CHANGE: 20180820
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ARMISTICE CAPITAL, LLC
CENTRAL INDEX KEY: 0001601086
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-29959
FILM NUMBER: 181029091
BUSINESS ADDRESS:
STREET 1: 510 MADISON AVENUE, 22ND FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10022
BUSINESS PHONE: (212) 231-4932
MAIL ADDRESS:
STREET 1: 510 MADISON AVENUE, 22ND FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10022
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Armistice Capital Master Fund Ltd.
CENTRAL INDEX KEY: 0001633584
STATE OF INCORPORATION: E9
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-29959
FILM NUMBER: 181029092
BUSINESS ADDRESS:
STREET 1: C/O ARMISTICE CAPITAL, LLC
STREET 2: 510 MADISON AVENUE, 22ND FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10022
BUSINESS PHONE: 212-231-4932
MAIL ADDRESS:
STREET 1: C/O ARMISTICE CAPITAL, LLC
STREET 2: 510 MADISON AVENUE, 22ND FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10022
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Boyd Steven
CENTRAL INDEX KEY: 0001706140
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-29959
FILM NUMBER: 181029093
MAIL ADDRESS:
STREET 1: 510 MADISON AVENUE
STREET 2: FL 22
CITY: NEW YORK
STATE: NY
ZIP: 10022
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PAIN THERAPEUTICS INC
CENTRAL INDEX KEY: 0001069530
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 911911336
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 7801 N CAPITAL OF TEXAS HIGHWAY
STREET 2: SUITE 260
CITY: AUSTIN
STATE: TX
ZIP: 78731
BUSINESS PHONE: 512-501-2444
MAIL ADDRESS:
STREET 1: 7801 N CAPITAL OF TEXAS HIGHWAY
STREET 2: SUITE 260
CITY: AUSTIN
STATE: TX
ZIP: 78731
4
1
ownership.xml
X0306
4
2018-08-16
0
0001069530
PAIN THERAPEUTICS INC
PTIE
0001601086
ARMISTICE CAPITAL, LLC
510 MADISON AVENUE
22ND FLOOR
NEW YORK
NY
10022
0
0
1
0
0001633584
Armistice Capital Master Fund Ltd.
C/O DMS CORPORATE SERVICES LTD.
20 GENESIS CLOSE, P.O. BOX 314
GRAND CAYMAN
E9
KY1-1104
CAYMAN ISLANDS
0
0
1
0
0001706140
Boyd Steven
C/O ARMISTICE CAPITAL, LLC
510 MADISON AVENUE, 22ND FLOOR
NEW YORK
NY
10022
0
0
1
0
Common Stock
2018-08-16
4
S
0
1200000
1.0185
D
2220000
D
Common Stock
2018-08-16
4
S
0
0
0
D
2220000
I
See Footnote
Common Stock
2018-08-16
4
S
0
0
0
D
2220000
I
See Footnote
Common Stock
2018-08-17
4
S
0
48000
0.9517
D
2172000
D
Common Stock
2018-08-17
4
S
0
0
0
D
2172000
I
See Footnote
Common Stock
2018-08-17
4
S
0
0
0
D
2172000
I
See Footnote
Common Stock
2018-08-20
4
S
0
8000
0.9068
D
2164000
D
Common Stock
2018-08-20
4
S
0
0
0
D
2164000
I
See Footnote
Common Stock
2018-08-20
4
S
0
0
0
D
2164000
I
See Footnote
The reported securities are directly owned by Armistice Capital Master Fund Ltd.
The reported securities are directly owned by Armistice Capital Master Fund Ltd., a Cayman Islands corporation, and may be deemed to be indirectly beneficially owned by Armistice Capital, LLC, as the investment manager of Armistice Capital Master Fund Ltd. The reported securities may also be deemed to be indirectly beneficially owned by Steven Boyd as Managing Member of Armistice Capital, LLC and Director of Armistice Capital Master Fund Ltd. Armistice Capital, LLC and Steven Boyd disclaim beneficial ownership of the reported securities except to the extent of their respective pecuniary interest therein, and this report shall not be deemed an admission that either of them are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
This constitutes the weighted average sale price. The prices range from $0.9851 to $1.0677. The Reporting Person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
This constitutes the weighted average sale price. The prices range from $0.9091 to $0.9998. The Reporting Person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Armistice Capital LLC, By: /s/ Steven Boyd, Managing Member
2018-08-20
Armistice Capital Master Fund Ltd. By: /s/ Steven Boyd, Director
2018-08-20
/s/ Steven Boyd
2018-08-20